United States Antimony to Uplist Shares to NYSE, Ending American Trading March 11
United States Antimony Corporation has been approved to uplist its common shares to the New York Stock Exchange effective March 11, 2026, with NYSE American trading ceasing thereafter. The uplisting is designed to enhance liquidity and market characteristics by adding a NYSE market maker to broaden institutional and retail participation.
1. Uplisting Approval and Timeline
United States Antimony Corporation has received approval to uplist its common shares to the New York Stock Exchange, with trading on the NYSE expected to begin at market open on March 11, 2026. Upon effectiveness, trading on the NYSE American will cease, while the company will remain listed on the NYSE Texas exchange under the symbol UAMY.
2. Liquidity and Trading Advantages
The uplisting introduces a NYSE market maker specialist with the goal of improving liquidity, tightening bid-ask spreads and broadening the shareholder base. Enhanced trading characteristics are expected to attract additional institutional and retail investors.
3. Company Operations and Growth Plans
US Antimony is the only fully integrated antimony producer and processor outside China and Russia, manufacturing antimony oxide, metal and trisulfide at facilities in Montana and Mexico. Its Bear River Zeolite unit in Idaho mines and processes zeolite, and the company expanded its mining portfolio with claims and leases in Montana, Alaska and Ontario during 2024 and 2025.